Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly to acquire worldwide license to Acrux's testosterone solution Axiron

March 17, 2010

Ipsen initiates dosing in two phase II studies of BIM-23A760 in cancer

March 17, 2010

Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave

March 16, 2010

Amylin, Lilly and Alkermes receive FDA's complete response letter on once-weekly exenatide

March 16, 2010

FDA requests additional information regarding Afrezza NDA for hyperglycemia in diabetes

March 16, 2010

Savient resubmits Krystexxa BLA for chronic gout to FDA

March 16, 2010

Xoma initiates phase II trial of XOMA-052 in type 1 diabetes

March 16, 2010

Sirtris Pharmaceuticals presents novel SIRT modulators

March 16, 2010

Ipsen grants Rhythm worldwide license for two programs in metabolic disorders

March 15, 2010

Korean scientists identify new dual PPAR-alpha/gamma activator

March 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...